COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,042 Articles (22,627 medRxiv, 8,415 bioRxiv)

Most recent first Previous |  Page 2217: Articles 22161-22170  | Next

High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in healthcare workers: results of the CoV-CONTACT prospective cohort
Tubiana, S., Burdet, C., Houhou, N., Thy, M., Manchon, P., Blanquart, F., Charpentier, C., Guedj, J., Alavoine, L., Behillil, S., Leclercq, A., Lucet, J.-C., Yazdanpanah, Y., Attia, M., Demeret, C., Rose, T., Bielicki, J. A., Bruijning-Verhagen, P., Goossens, H., Descamps, D., van der Werf, S., Lina, B., Duval, X.
10.1101/2020.09.17.20194860 — Posted: 2020-09-18
Investigating the implications of COVID-19 for the rural and remote population of Northern Ontario using a mathematical model
Savage, D., Fisher, A., Choudhury, S., Ohle, R., Strasser, R., Orkin, A., Mago, V.
10.1101/2020.09.17.20196949 — Posted: 2020-09-18
Variation of SARS-CoV-2 viral loads by sample type, disease severity and time: a systematic review
Edwards, T., Santos, V. S., Wilson, A. L., Cubas-Atienzar, A. I., Kontogianni, K., Williams, C. T., Adams, E. R., Cuevas, L. E.
10.1101/2020.09.16.20195982 — Posted: 2020-09-18
THE REMOTE ANALYSIS OF BREATH SOUND IN COVID-19 PATIENTS: A SERIES OF CLINICAL CASES
Furman, E. G., Charushin, A., Eirikh, E., Malinin, S., Sheludko, V., Sokolovsky, V., Furman, G.
10.1101/2020.09.16.20195289 — Posted: 2020-09-18
COPD in the time of COVID-19: An analysis of acute exacerbations and reported behavioural changes in patients with COPD
McAULEY, H. J. C., Hadley, K., Elneima, O., Brightline, C. E., Evans, R., Steiner, M. C., Greening, N.
10.1101/2020.09.18.20197202 — Posted: 2020-09-18
Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
Van Walle, I., Leitmeyer, K., Broberg, E. K., The European COVID-19 microbiological laboratories group
10.1101/2020.09.16.20195917 — Posted: 2020-09-18
Ranking the relative importance of COVID-19 immunisation strategies: a survey of expert stakeholders in Canada
Zhao, L., Ismail, S. J., Tunis, M. C.
10.1101/2020.09.16.20196295 — Posted: 2020-09-18
Disparities in COVID-19 Related Mortality in U.S. Prisons and the General Population
Nowotny, K. M., Cloud, D., Wurcel, A. G., Brinkley-Rubinstein, L.
10.1101/2020.09.17.20183392 — Posted: 2020-09-18 Discussion: Offsite
COVID-19 pediatric mortality rates are heterogenous between countries
Gonzalez-Garcia, N., Miranda-Lora, A. L., Mendez-Galvan, J., Granados-Riveron, J. T., Nieto-Zermeno, J., Garduno-Espiosa, J., CASTILLA-PEON, M. F.
10.1101/2020.09.17.20196832 — Posted: 2020-09-18
Seroprevalence of Antibodies to SARS-CoV-2 in US Blood Donors
Vassallo, R. R., Bravo, M. D., Dumont, L. J., Hazegh, K., Kamel, H.
10.1101/2020.09.17.20195131 — Posted: 2020-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).